4th Edition Hands-on Molecular Tools Workshop

The Hands-on Molecular Tools workshop aims to cover the fundamental principles and standard techniques used in Molecular Biology and will be taught by experts from CF, FCT-UNL and FCUL/cE3c.

This course will incorporate theoretical and practical classes, where the participants will acquire experience on RNA extraction, cDNA synthesis, PCR, restriction enzyme digestion, electrophoresis, plasmid DNA isolation, as well as, bioinformatics analysis and experimental design of a cloning project. 

Champalimaud Research Symposium 2025

The symposium, themed Neuro-Cybernetics at Scale, draws inspiration from the recent advances in AI and machine learning, where scaling has unlocked unprecedented performance. We believe neuroscience may be approaching a similar inflection point. By convening researchers in experimental neuroscience, robotics, machine learning, control theory, and theoretical neuroscience, we aim to explore how ideas of scaling and feedback can shape the future of systems neuroscience.

2nd Botton-Champalimaud International Pancreatic Cancer Conference

The first edition of the Botton-Champalimaud International Pancreatic Conference, hosted at the prestigious Botton-Champalimaud Pancreatic Cancer Centre, was a landmark event in 2024, bringing together leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements in pancreatic cancer diagnosis, treatment, and care.

Deep Decisions: Uncovering the Subcortical Role in Perceptual Choice

Host

Naz Belkaya, MSc, Circuit Dynamics and Computation


Venue

Seminar room

22 May 2025

Recommendations for the clinical use of psychedelic substances presented at the Champalimaud Foundation

It was a happy coincidence: the final text of the Recommendations of the Multidisciplinary and Multiprofessional Working Group on the Clinical Use of Psychedelic Substances was released on the same day that the Portuguese National Health System announced its decision to fully reimburse the treatment of resistant depression with a substance called esketamine.

20 May. 2025

Post-Doctoral Fellow in Pancreatic Cancer Research – Cancer Systems Laboratory Botton-Champalimaud

Research
Application Starts: 20 May. 2025

[PLEASE NOTE THAT THE RECRUITMENT PROCESS FOR THIS CALL IS NOW CLOSED]

Position overview

We are seeking a highly motivated and skilled Post-Doctoral Fellow to join our dynamic research team at the Botton-Champalimaud Pancreatic Cancer Centre. This prestigious center is dedicated to advancing pancreatic cancer research and treatment through innovative approaches and multidisciplinary collaboration.

19 May. 2025

Game/VR Developer

Research
Application Starts: 19 May. 2025

[PLEASE NOTE THAT THE RECRUITMENT PROCESS FOR THIS CALL IS NOW CLOSED]

Offer Description

A Call for one research fellowship (Bolsa de Investigação) for a Game/VR Developer is open at Fundação D. Anna de Sommer Champalimaud e Dr.

Emerging Roles of Lipid Metabolism in Cancer Metastasis

Host

Ana Luísa Correia, PhD, Cancer Dormancy & Immunity


Venue

Seminar room

08 May 2025

Parkinson’s Disease might be detected much earlier with a simple brain scan

An international team, led by researchers at the Champalimaud Foundation (CF), has shown – for the first time in a realistic way – that it may be possible, in the future, to diagnose Parkinson’s disease (PD) years earlier, by scanning people’s brains with functional magnetic resonance imaging (fMRI). Although there are treatment options after diagnosis, there is no cure.  Therapies are continually improving — with ongoing research aiming to slow or even alter the course of the disease - investing in the research of methods that enable much earlier diagnosis is crucial.

06 May 2025

How AI Is Transforming PET/CT Analysis

Analysing these scans can also be time-consuming and complex, as doctors need to pore over countless images, looking for often tiny details.

So, any new imaging analysis technique that is faster and more precise is always welcome: a new paper (recently published in the Journal of Nuclear Medicine) reveals that the Champalimaud Foundation’s Nuclear Medicine-Radiopharmacology Unit has managed just that by using Deep Learning (DL) Artificial Intelligence (AI).

Subscribe to Research Groups
Loading
Please wait...